The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair

Osteoarthritis and Cartilage

Volumn 21, Issue 1, 2013, Pages 175-185

  Mifune, Y ^a,b   Matsumoto, T ^a,b   Takayama, K ^a,b   Ota, S ^a,b   Li, H ^a,b   Meszaros, L B ^a   Usas, A ^a   Nagamune, K ^c   Gharaibeh, B ^a,b   Fu, F H ^b   Huard, J ^a,b,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FUKUI   (Japan)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Muscle derived stem cells; Osteoarthritis; Platelet rich plasma

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; COLLAGEN TYPE 2; VASCULOTROPIN RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; MOUSE; MUSCLE DERIVED STEM CELL; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGENERATIVE MEDICINE; SKELETAL MUSCLE; STEM CELL; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; TREATMENT DURATION;

ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEIN 4; CARTILAGE, ARTICULAR; CHONDROCYTES; COLLAGEN TYPE II; FEMALE; OSTEOARTHRITIS, KNEE; PLATELET-RICH PLASMA; RATS; RATS, NUDE; STEM CELL TRANSPLANTATION; STEM CELLS; STIFLE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84871925610     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.09.018     Document Type: Article

References (44)

1. Marx R.E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004, 62(4):489-496.
2. Engebretsen L., Steffen K., Alsousou J., Anitua E., Bachl N., Devilee R., et al. IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med 2010, 44(15):1072-1081.
3. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., Georgeff K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998, 85(6):638-646.
4. Sanchez A.R., Sheridan P.J., Kupp L.I. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003, 18(1):93-103.
5. Mehta S., Watson J.T. Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma 2008, 22(6):432-438.
6. Foster T.E., Puskas B.L., Mandelbaum B.R., Gerhardt M.B., Rodeo S.A. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009, 37(11):2259-2272.
7. Sanchez M., Anitua E., Orive G., Mujika I., Andia I. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med 2009, 39(5):345-354.
8. Hall M.P., Band P.A., Meislin R.J., Jazrawi L.M., Cardone D.A. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg 2009, 17(10):602-608.
9. Camargo P.M., Lekovic V., Weinlaender M., Vasilic N., Madzarevic M., Kenney E.B. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res 2002, 37(4):300-306.
10. Drengk A., Zapf A., Sturmer E.K., Sturmer K.M., Frosch K.H. Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 2009, 189(5):317-326.
11. Wu W., Chen F., Liu Y., Ma Q., Mao T. Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model. J Oral Maxillofac Surg 2007, 65(10):1951-1957.
12. Sun Y., Feng Y., Zhang C.Q., Chen S.B., Cheng X.G. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop 2010, 34(4):589-597.
13. Deasy B.M., Gharaibeh B.M., Pollett J.B., Jones M.M., Lucas M.A., Kanda Y., et al. Long-term self-renewal of postnatal muscle-derived stem cells. Mol Biol Cell 2005, 16(7):3323-3333.
14. Cao B., Zheng B., Jankowski R.J., Kimura S., Ikezawa M., Deasy B., et al. Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol 2003, 5(7):640-646.
15. Jankowski R.J., Deasy B.M., Cao B., Gates C., Huard J. The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci 2002, 115(Pt 22):4361-4374.
16. Lee J.Y., Qu-Petersen Z., Cao B., Kimura S., Jankowski R., Cummins J., et al. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000, 150(5):1085-1100.
17. Peng H., Wright V., Usas A., Gearhart B., Shen H.C., Cummins J., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 2002, 110(6):751-759.
18. Shen H.C., Peng H., Usas A., Gearhart B., Cummins J., Fu F.H., et al. Ex vivo gene therapy-induced endochondral bone formation: comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. Bone 2004, 34(6):982-992.
19. Wright V., Peng H., Usas A., Young B., Gearhart B., Cummins J., et al. BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther 2002, 6(2):169-178.
20. Adachi N., Sato K., Usas A., Fu F.H., Ochi M., Han C.W., et al. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol 2002, 29(9):1920-1930.
21. Kuroda R., Usas A., Kubo S., Corsi K., Peng H., Rose T., et al. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 2006, 54(2):433-442.
22. Wakitani S., Yamamoto T. Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defect. Microsc Res Tech 2002, 58(1):14-18.
23. Matsumoto T., Cooper G.M., Gharaibeh B., Meszaros L.B., Li G., Usas A., et al. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum 2009, 60(5):1390-1405.
24. Plachokova A.S., van den Dolder J., Stoelinga P.J., Jansen J.A. The bone regenerative effect of platelet-rich plasma in combination with an osteoconductive material in rat cranial defects. Clin Oral Implants Res 2006, 17(3):305-311.
25. Pritzker K.P., Gay S., Jimenez S.A., Ostergaard K., Pelletier J.P., Revell P.A., et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 2006, 14(1):13-29.
26. Baltzer A.W., Moser C., Jansen S.A., Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage 2009, 17(2):152-160.
27. Pufe T., Harde V., Petersen W., Goldring M.B., Tillmann B., Mentlein R. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J Pathol 2004, 202(3):367-374.
28. Enomoto H., Inoki I., Komiya K., Shiomi T., Ikeda E., Obata K., et al. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 2003, 162(1):171-181.
29. Vogel J.P., Szalay K., Geiger F., Kramer M., Richter W., Kasten P. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. Platelets 2006, 17(7):462-469.
30. Kakudo N., Minakata T., Mitsui T., Kushida S., Notodihardjo F.Z., Kusumoto K. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg 2008, 122(5):1352-1360.
31. He L., Lin Y., Hu X., Zhang Y., Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 108(5):707-713.
32. Akeda K., An H.S., Okuma M., Attawia M., Miyamoto K., Thonar E.J., et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage 2006, 14(12):1272-1280.
33. Caceres M., Hidalgo R., Sanz A., Martinez J., Riera P., Smith P.C. Effect of platelet-rich plasma on cell adhesion, cell migration, and myofibroblastic differentiation in human gingival fibroblasts. J Periodontol 2008, 79(4):714-720.
34. Mishra A., Tummala P., King A., Lee B., Kraus M., Tse V., et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 2009, 15(3):431-435.
35. Ng F., Boucher S., Koh S., Sastry K.S., Chase L., Lakshmipathy U., et al. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 2008, 112(2):295-307.
36. Anitua E., Sanchez M., Zalduendo M.M., de la Fuente M., Prado R., Orive G., et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif 2009, 42(2):162-170.
37. Spreafico A., Chellini F., Frediani B., Bernardini G., Niccolini S., Serchi T., et al. Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem 2009, 108(5):1153-1165.
38. Chen P., Carrington J.L., Hammonds R.G., Reddi A.H. Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2B (BMP-2B) and modulation by transforming growth factor beta 1 and beta 2. Exp Cell Res 1991, 195(2):509-515.
39. Goepfert C., Lutz V., Lunse S., Kittel S., Wiegandt K., Kammal M., et al. Evaluation of cartilage specific matrix synthesis of human articular chondrocytes after extended propagation on microcarriers by image analysis. Int J Artif Organs 2010, 33(4):204-218.
40. Sanchez M., Anitua E., Azofra J., Aguirre J.J., Andia I. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol 2008, 26(5):910-913.
41. Kon E., Buda R., Filardo G., Di Martino A., Timoncini A., Cenacchi A., et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 2010, 18(4):472-479.
42. Zimmerman G.A., Weyrich A.S. Immunology. Arsonists in rheumatoid arthritis. Science 2010, 327(5965):528-529.
43. Guingamp C., Gegout-Pottie P., Philippe L., Terlain B., Netter P., Gillet P. Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum 1997, 40(9):1670-1679.
44. Janusz M.J., Hookfin E.B., Heitmeyer S.A., Woessner J.F., Freemont A.J., Hoyland J.A., et al. Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors. Osteoarthritis Cartilage 2001, 9(8):751-760.